Evotec SE 2021 SR
The report highlights Evotec's commitment to drug discovery and development, focusing on precision medicine and global health challenges like tuberculosis and pandemic preparedness through its PRRoTECT platform. In 2021, the company expanded its workforce to 4,198 employees and achieved its target of 31% women in senior executive management. Environmentally, Evotec committed to the Science Based Targets initiative (SBTi) to align with a 1.5°C warming limit and sourced 100% renewable energy for its German sites. The company also improved its ESG ratings and implemented a software-based system for systematic emission data collection.
Company: Evotec SE
Sector: Manufacturing
Country: Germany
Year: 2021
Type: SR
Pages: 48
Back to company
Evotec SE
Sustainability Report
The report highlights Evotec's commitment to drug discovery and development, focusing on precision medicine and global health challenges like tuberculosis and pandemic preparedness through its PRRoTECT platform. In 2021, the company expanded its workforce to 4,198 employees and achieved its target of 31% women in senior executive management. Environmentally, Evotec committed to the Science Based Targets initiative (SBTi) to align with a 1.5°C warming limit and sourced 100% renewable energy for its German sites. The company also improved its ESG ratings and implemented a software-based system for systematic emission data collection.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Apr 26, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women in Management
Net Zero Target
Employees